Ligong Lu

10PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 18, 2024
ACSL6-activated IL-18R1-NF-κB promotes IL-18-mediated tumor immune evasion and tumor progression.

Yuqin Di, Ziyang Wang, Jing Xiao

|May 10, 2024
Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer.

Jing Xiao, Xinyang Yu, Fanlin Meng

|Apr 22, 2024
SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity.

Nan Fang, Bing Liu, Qiuzhong Pan

|Feb 26, 2024
SPOP point mutations regulate substrate preference and affect its function.

Yanran Deng, Wenhao Ding, Kaize Ma

|Nov 21, 2023
γδ T cells: origin and fate, subsets, diseases and immunotherapy.

Yi Hu, Qinglin Hu, Yongsheng Li

|Nov 06, 2023
A Functional Stent Encapsulating Radionuclide in Temperature-Memory Spiral Tubes for Malignant Stenosis of Esophageal Cancer.

Huanqing Guo, Tao Huang, Yi Dai

Pageof 2

Frequent Collaborators

2 joint publications

Meixiao Zhan

1 joint publications

Yin-Chu Ma

1 joint publications

Xuanjun Zhang

1 joint publications

Yufeng Ding